Open access · OA
via OpenAlex
New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms
Tamar Tchkonia, Allyson K. Palmer, James L. Kirkland
The Journal of Clinical Endocrinology & Metabolism · 2020 · ▲ 119 citations
Genomic instability
Epigenetic alterations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Rapamycin / mTOR inhibition
Metformin
Senolytics
Human
Abstract
The elderly population is increasing faster than other segments of the population throughout the world. Age is the leading predictor for most chronic diseases and disorders, multimorbidity, geriatric syndromes, and impaired ability to recover from accidents or illnesses. Enhancing the duration of health and independence, termed healthspan(definition), would be more desirable than extending lifespan merely by prolonging the period of morbidity toward the end of life. The geroscience hypothesis posits that healthspan can be extended by targeting fundamental aging mechanisms, rather than attempting to address each age-related disease one at a time, only so the afflicted individual survives disabled and dies shortly afterward of another age-related disease. These fundamental aging mechanisms include, among others, chronic inflammation, fibrosis, stem cell/ progenitor dysfunction, DNA damage, epigenetic changes, metabolic shifts, destructive metabolite generation, mitochondrial dysfunction(definition), misfolded or aggregated protein accumulation, and cellular senescence(definition). These processes appear to be tightly interlinked, as targeting any one appears to affect many of the rest, underlying our Unitary Theory of Fundamental Aging Mechanisms. Interventions targeting many fundamental aging processes are being developed, including dietary manipulations, metformin, mTOR(definition) (mechanistic target of rapamycin(definition)) inhibitors, and senolytics(definition), which are in early human trials. These interventions could lead to greater healthspan benefits than treating age-related diseases one at a time. To illustrate these points, we focus on cellular senescence and therapies in development to target senescent cells. Combining interventions targeting aging mechanisms with disease-specific drugs could result in more than additive benefits for currently difficult-to-treat or intractable diseases. More research attention needs to be devoted to targeting fundamental aging processes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/clinem/dgaa728
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Tchkonia, T., Palmer, A.K., & Kirkland, J.L. (2020). New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms. <em>The Journal of Clinical Endocrinology & Metabolism</em>. https://doi.org/10.1210/clinem/dgaa728
Vancouver
Tchkonia T, Palmer AK, Kirkland JL. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms. The Journal of Clinical Endocrinology & Metabolism. 2020. doi:10.1210/clinem/dgaa728.
BibTeX
@article{tamar2020NewHor,
title = {New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms},
author = {Tamar Tchkonia and Allyson K. Palmer and James L. Kirkland},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2020},
doi = {10.1210/clinem/dgaa728},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Plastic & Reconstructive Surgery 2021
Preprint · OA
Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation
Journal of Translational Medicine 2017
Open access · CC-BY
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives
PubMed 2019
Preprint · OA
Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
British Journal of Clinical Pharmacology 2015
Open access · OA
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
Nestlé Nutrition Institute Workshop series 2015
Preprint · OA
Cellular Senescence and the Biology of Aging, Disease, and Frailty
Journal of Clinical Investigation 2022
Open access · CC-BY